These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7607835)
1. Applications of the polymerase chain reaction (PCR) in diagnosis. Fanning S; Joyce C; Corbett A; O'Mullane J; Cryan B Ir J Med Sci; 1995; 164(2):116-21. PubMed ID: 7607835 [TBL] [Abstract][Full Text] [Related]
2. Co-amplification of the cystic fibrosis delta F508 mutation with the HLA DQA1 sequence in single cell PCR: implications for improved assessment of polar bodies and blastomeres in preimplantation diagnosis. Wu R; Cuppens H; Buyse I; Decorte R; Marynen P; Gordts S; Cassiman JJ Prenat Diagn; 1993 Dec; 13(12):1111-22. PubMed ID: 7513888 [TBL] [Abstract][Full Text] [Related]
3. Optimal polymerase chain reaction amplification for preimplantation diagnosis in cystic fibrosis (delta F508). Cui KH; Haan EA; Wang LJ; Matthews CD BMJ; 1995 Aug; 311(7004):536-40. PubMed ID: 7545043 [TBL] [Abstract][Full Text] [Related]
4. PCR amplified HLA DQ alpha and DQ beta DNA typed by dot-blot hybridization and direct sequence for suspect. Lee JC; Chang JG J Formos Med Assoc; 1992 May; 91(5):483-6. PubMed ID: 1358324 [TBL] [Abstract][Full Text] [Related]
5. Analysis and interpretation of the HLA DQ alpha "1.1 weak-signal" observed during the PCR-based typing method. Crouse CA; Vincek V; Caraballo BK J Forensic Sci; 1994 Jan; 39(1):41-51. PubMed ID: 8113712 [TBL] [Abstract][Full Text] [Related]
6. A 31-mutation assay for cystic fibrosis testing in the clinical molecular diagnostics laboratory. Wall J; Cai S; Chehab FF Hum Mutat; 1995; 5(4):333-8. PubMed ID: 7627189 [TBL] [Abstract][Full Text] [Related]
7. The polymerase chain reaction and post-mortem forensic identity testing: application of amplified D1S80 and HLA-DQ alpha loci to the identification of fire victims. Sajantila A; Ström M; Budowle B; Karhunen PJ; Peltonen L Forensic Sci Int; 1991 Oct; 51(1):23-34. PubMed ID: 1752592 [TBL] [Abstract][Full Text] [Related]
8. Identification of the I507 deletion by site-directed mutagenesis. Orozco L; Friedman K; Chávez M; Lezana JL; Villarreal MT; Carnevale A Am J Med Genet; 1994 Jun; 51(2):137-9. PubMed ID: 8092189 [TBL] [Abstract][Full Text] [Related]
9. Efficiency and accuracy of polymerase-chain-reaction assay for cystic fibrosis allele delta F508 in single cell. Liu J; Lissens W; Devroey P; Van Steirteghem A; Liebaers I Lancet; 1992 May; 339(8803):1190-2. PubMed ID: 1349937 [TBL] [Abstract][Full Text] [Related]
10. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Olerup O; Aldener A; Fogdell A Tissue Antigens; 1993 Mar; 41(3):119-34. PubMed ID: 8316943 [TBL] [Abstract][Full Text] [Related]
11. Genetic typing of the DQA1*4 alleles by restriction enzyme digestion of the PCR product obtained with the DQ Alpha Amplitype kit. Salazar M; Williamson J; Bing DH J Forensic Sci; 1994 Mar; 39(2):518-25. PubMed ID: 8195762 [TBL] [Abstract][Full Text] [Related]
12. A strategy for high throughput HLA-DQ typing. Feolo M; Fuller TC; Taylor M; Zone JJ; Neuhausen SL J Immunol Methods; 2001 Dec; 258(1-2):65-71. PubMed ID: 11684124 [TBL] [Abstract][Full Text] [Related]
13. Nearly 80% of cystic fibrosis heterozygotes and 64% of couples at risk may be detected through a unique screening of four mutations by ASO reverse dot blot. Serre JL; Taillandier A; Mornet E; Simon-Bouy B; Boué J; Boué A Genomics; 1991 Dec; 11(4):1149-51. PubMed ID: 1783382 [TBL] [Abstract][Full Text] [Related]
14. Use of stable dye-DNA intercalating complexes to detect cystic fibrosis mutations. Axton RA; Brock DJ Mol Cell Probes; 1994 Jun; 8(3):245-50. PubMed ID: 7969200 [TBL] [Abstract][Full Text] [Related]
15. Reduced allele dropout in single-cell analysis for preimplantation genetic diagnosis of cystic fibrosis. Ray PF; Winston RM; Handyside AH J Assist Reprod Genet; 1996 Feb; 13(2):104-6. PubMed ID: 8688580 [TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course. Poller W; Faber JP; Scholz S; Olek K; Müller KM Klin Wochenschr; 1991 Sep; 69(14):657-63. PubMed ID: 1749205 [TBL] [Abstract][Full Text] [Related]
17. Mutation detection by mismatch binding protein, MutS, in amplified DNA: application to the cystic fibrosis gene. Lishanski A; Ostrander EA; Rine J Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2674-8. PubMed ID: 7511817 [TBL] [Abstract][Full Text] [Related]
18. Segregation of delta F508 and normal CFTR alleles in human sperm. Williams C; Davies D; Williamson R Hum Mol Genet; 1993 Apr; 2(4):445-8. PubMed ID: 7684944 [TBL] [Abstract][Full Text] [Related]
19. Modified PCR-RFLP method for HLA-DPB1 and -DQA1 genotyping. Ota M; Seki T; Nomura N; Sugimura K; Mizuki N; Fukushima H; Tsuji K; Inoko H Tissue Antigens; 1991 Aug; 38(2):60-71. PubMed ID: 1683029 [TBL] [Abstract][Full Text] [Related]
20. Application of silver staining to the rapid typing of the polymorphism of HLA-DQ alleles by enzymatic amplification and allele-specific restriction fragment length polymorphism. Ju LY; Gu XF; Larger E; Krishnamoorthy R; Charron D Electrophoresis; 1991 Apr; 12(4):270-3. PubMed ID: 1712722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]